News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
Top Breaking News
Gilead Sciences, Inc. (GILD) Will Employ 500 People At Massive Southern California Plant     9/30/2014
Baxter International, Inc. (BAX) Will House 400 Staffers At New R&D Center In Boston     9/30/2014
Johnson & Johnson (JNJ) Bags SSF's Alios BioPharma For $1.7 Billion Cash     9/30/2014
Impressed With MacroGenics, Inc. (MGNX), Takeda Pharmaceutical Co. Ltd. (TKPYY) Draws Up Second DART Therapeutics Pact Worth $1.6 Billion     9/30/2014
Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN)'s Dupilumab Successful In Phase 2 Study     9/30/2014
Abbott Laboratories (ABT), Pfizer (PFE) Absence At PM Breakfast Meeting Gets Noticed     9/30/2014
Pfizer (PFE) Starts New Viagra Commercials Targeting Women     9/30/2014
Consort Medical Scoops Up Aesica For $374 Million     9/30/2014
Strides Arcolab Limited Snags Shasun Pharma In All Stock Deal Worth Over $221 Million     9/30/2014
MannKind Corporation (MNKD) Pockets $150 Million Upfront Payment From Sanofi (France) (SAN.PA)     9/30/2014
Bay Area Startup Allakos Locks In Another $10 Million     9/30/2014
Mapp Biopharmaceutical's Ebola Drug Production Set for Texas, Possibly North Carolina     9/30/2014
Pfizer (PFE), Kyowa Hakko Kirin Team Up On Immuno-Oncology Combination Study     9/30/2014
Acasti Pharma Announces Positive Top-Line Pharmacokinetic Results     9/30/2014
Nimbus Discovery Appoints Donald Nicholson, Ph.D. As Chief Executive Officer     9/30/2014

Featured Stories
Biotech Firm Backed By Mexican Billionaire Carlos Slim Files To Go Public     9/30/2014
How Your Fingers Can Predict Everything From Penis Size To Sexual Orientation     9/30/2014
Childhood Asthma Linked To Lack Of Ventilation For Gas Stoves, Oregon State University Study     9/30/2014
Design Power: Patients Play Researchers In Drug Trials     9/30/2014
Gilead Sciences, Inc. (GILD) Looks To Erase Bristol-Myers Squibb Company (BMY)'s Early Hep C Lead     9/30/2014
Centers for Disease Control and Prevention (CDC) Investigates Limb Paralysis In Kids; Is Enterovirus To Blame?     9/30/2014
Sleep Twitches Light Up The Brain, University of Iowa Study     9/30/2014
Antibiotics "Linked To Childhood Obesity," University of Pennsylvania Study     9/30/2014
Healthy Fats Help Diseased Heart Muscle Process, Use Fuel, University of Illinois Study     9/30/2014
Hundreds Of Firms Join Global Hunt For Copycat Biotech Drugs     9/29/2014
In 2-Minute Drill For Startups, A Winning Pitch For Clinical Trials     9/29/2014
7 Foods That Fight High Cholesterol     9/29/2014
Autistic Kids Are More Sedentary Than Their Peers, Oregon State University Study Shows     9/29/2014
Stress Might Be Even More Unhealthy For The Obese, Brandeis University Study     9/29/2014
Cells From Placentas Safe For Patients With Multiple Sclerosis, Mount Sinai School of Medicine Study     9/29/2014

More News
Alimera Sciences (ALIM), pSivida Corp (PSDV) Eye Implant Finally Wins FDA Approval     9/29/2014
Cesca Therapeutics Announces Approval Of Its AXP ® Autoxpress ® System In Taiwan     9/29/2014
Allergan Inc. (AGN) Announces FDA Approves Revised Indication For OZURDEX ® (Dexamethasone Intravitreal Implant) 0.7 Mg For The Treatment Of Diabetic Macular Edema     9/29/2014
Bristol-Myers Squibb Company (BMY) Release: European Medicines Agency Validates The Marketing Authorization Application For Nivolumab In Non-Small Cell Lung Cancer     9/29/2014
Janssen Research & Development Release: ZYTIGA® Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis In Chemotherapy-Naive Men With Metastatic Castration-Resistant Prostate Cancer     9/29/2014
Keryx Biopharmaceuticals (KERX) Initiates Pivotal Phase 3 Study Of Ferric Citrate For The Treatment Of Iron Deficiency Anemia In Patients With Non-Dialysis Dependent Chronic Kidney Disease     9/29/2014
Agile Therapeutics, Inc. Announces Dosing Of First Patients In Twirla® Phase 3 SECURE Study     9/29/2014
Janssen Pharmaceutical Inc. Release: ZYTIGA®* Plus Prednisone Demonstrates Statistically Significant Overall Survival In Men With Advanced Prostate Cancer Prior To Chemotherapy     9/29/2014
SALVAT Announces Positive Top-Line Results From Two Phase 3 Studies Of Its Novel Otic Antibiotic/Steroid Combination Solution In The Treatment Of AOMT With Tympanostomy Tubes     9/29/2014
Exelixis, Inc. (EXEL) Announces Positive Results From Phase 3 Pivotal Trial Of Cobimetinib In Combination With Vemurafenib In Patients With BRAF V600 Mutation-Positive Advanced Melanoma     9/29/2014
Roche (RHHBY)’s Perjeta Regimen Extended The Lives Of People With An Aggressive Type Of Metastatic Breast Cancer By 15.7 Months Compared To Herceptin And Chemotherapy     9/29/2014
Roche (RHHBY)’s Investigational Combination Of Cobimetinib Plus Zelboraf® (Vemurafenib) Provided Significant Benefit To People With Advanced Melanoma Over Zelboraf Alone     9/29/2014
Seattle Genetics, Inc. (SGEN) And Takeda Pharmaceutical Co. Ltd. (TKPYY) Announce Positive Data From Phase 3 AETHERA Clinical Trial Of ADCETRIS® (Brentuximab Vedotin) For Consolidation In Post-Transplant Hodgkin Lymphoma     9/29/2014
Provectus Biopharmaceuticals Inc. Data Presented At ESMO 2014 Congress Show Ablative, Bystander Effects Of PV-10     9/29/2014
Bristol-Myers Squibb Company (BMY) Positive Phase 3 Data For Opdivo (Nivolumab) In Advanced Melanoma Patients Previously Treated With Yervoy (Ipilimumab) Presented At The ESMO 2014 Congress; First Phase 3 Results Presented For A PD-1 Immune Checkpoint Inhibitor     9/29/2014
Genentech (RHHBY)’s Investigational Combination Of Cobimetinib Plus Zelboraf (Vemurafenib) Provided Significant Benefit To People With Advanced Melanoma Over Zelboraf Alone     9/29/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical Trial In Patients With Lambert-Eaton Myasthenic Syndrome (LEMS)     9/29/2014
Endocyte, Inc. (ECYT) Release: Phase 2b TARGET Trial Results Show Improved Survival In Adenocarcinoma Non-Small Cell Lung Cancer Patients Treated With Endocyte's Vintafolide     9/29/2014
CytRx Corporation (CYTR) Receives Multiple FDA Orphan Drug Designations For Aldoxorubicin For The Treatment Of Glioblastoma, Small Cell Lung Cancer And Ovarian Cancer     9/29/2014
Bionomics Limited (BNO.AX) Presents BNC105 Phase 2 Renal Cancer Trial Biomarker Data     9/29/2014
Acasti Pharmai Reports Successful Capre® Phase 2 TRIFECTA Results Proving Statistically Significant Improvements In Triglycerides & Non-HDL-C     9/29/2014
Viralytics Ltd (VLA.AX) Release: Updated Positive Data From Phase 2 Trial Of CAVATAK In Late-Stage Melanoma     9/29/2014
TRANSGENE (ENX:TNG) Presents Additional Positive Clinical Data From Phase 2b Part Of TIME Trial With TG4010 At ESMO     9/29/2014
Karyopharm Therapeutics (KPTI) Announces Clinical Data For Selinexor (KPT-330) In Advanced Solid Tumors     9/29/2014
AVEO Oncology (AVEO) Announces Results From Phase 2 Clinical Studies Of Tivozanib In Patients With Advanced Colorectal And Kidney Cancers Presented At ESMO 2014 Congress     9/29/2014
Puma Biotechnology (PBYI) Announces Positive Initial Results From PB272 Phase II Trial In HER2 Mutated Non-Small Cell Lung Cancer     9/29/2014
Biothera To Present Late-Breaking Data From Its Phase 2     9/29/2014
Ipsen (IPN.PA) Presents Preliminary Results Of Exploratory Proof-Of-Concept Study With Tasquinimod In Four Advanced Tumor Types At The ESMO 2014 Congress     9/29/2014
AVEO Oncology (AVEO) And Biodesix, Inc. Announce Exploratory Analysis Of Veristrat-Selected Patients With Non-Small Cell Lung Cancer In Phase 2 Study Of Ficlatuzumab Presented At ESMO 2014 Congress     9/29/2014
Amarantus BioSciences, Inc. Requests Pre-IND Feedback From FDA For Eltoprazine Phase 2ib Parkinson's Disease Levodopa-Induced Dyskinesia Clinical Trial     9/29/2014
Clovis Oncology (CLVS) Release: Data From Ongoing Phase 2 Studies Of Rucaparib In Ovarian Cancer Demonstrate Safety And Clinical Activity, Validate Differentiated Strategy     9/29/2014
OncoMed Pharmaceuticals, Inc. (OMED)'s Demcizumab Phase 1b Clinical Trials Show Encouraging Safety And Anti-Tumor Activity At ESMO     9/29/2014
Ariad Pharmaceuticals, Inc. (ARIA) Presents Updated Clinical Data On AP26113 In Patients With ALK+ Non-Small Cell Lung Cancer     9/29/2014
Ignyta (RXDX) Announces Interim Data From RXDX-101 Phase I Clinical Trial At 2014 ESMO Congress     9/29/2014
AstraZeneca PLC (AZN) Release: AZD9291 Shows Durable Clinical Response In Patients With Advanced EGFR Mutation Positive Non-Small Cell Lung Cancer At The ESMO 2014 Congress     9/29/2014
Helix Biopharma (CC:HBP) Initiates Enrollment For Tenth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47     9/29/2014
CEL-SCI (CVM) & U.S. Navy Administer Multikine To First Volunteer Patient In Phase I Clinical Trial For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients     9/29/2014
FDA Approves NeuroGenetic Pharmaceuticals, Inc. Application To Begin Clinical Trials For Its NGP 555 Compound To Treat And Prevent Alzheimer’s Disease     9/29/2014
Infection Prevention and Control Canada (IPAC Canada) Release: Enterovirus - D68: What You Need To Know     9/29/2014
Verona Pharma (VRP.L) New Data Supports RPL554 As A Potential Novel Cystic Fibrosis Therapy     9/29/2014
Cancer Treatment Institute Of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination Of 3-Bromopyruvate And Salinomycin For Treatment Of Multiple Types Of Cancer     9/29/2014
Manzo Pharmaceuticals Announces Successful Results In Laboratory Tests Of Its Lactose Intolerance Probiotic Lacto-Freedom     9/29/2014
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Glioma     9/29/2014
Acura Pharmaceuticals, Inc. (ACUR) Hydrocodone Bitartrate With Acetaminophen Tablets Meet Clinical Endpoints     9/29/2014
Chiltern International Ltd. Acquires Pacific Clinical Research Pte Limited And Expands Operations And Therapeutic Depth In Asia-Pacific     9/29/2014
ADM Tronics Unlimited (ADMT) Joins Triotech Ventures Technology Consortium     9/29/2014
Merck & Co. (MRK) Partners With eSSENTIAL Accessibility To Offer App For People With Disabilities     9/29/2014
Galmed Pharmaceuticals And Itamar Medical Ltd. To Collaborate On Assessing Aramchol's Effect On Endothelial Function     9/29/2014
Sigmoid Pharma Enters Into A Licence Agreement With PendoPharm Inc. For Commercialisation Rights To CyCol® In Canada     9/29/2014
Agilent Technologies Inc. (A) To Collaborate With Agilent Technologies, Inc. (Santa Clara, California) (A) On Metabolomics MRM Library-Software Solution To Accelerate Cell Biology, Disease Research     9/29/2014
Benchworks Collaborates With Boston Therapeutics, Inc. To Market Sugardown®     9/29/2014
Yale University And Leica Microsystems Partner To Establish Microscopy Center Of Excellence     9/29/2014
Ohio Clinical Trials Collaborative Launches In European Market     9/29/2014
A*STAR's Institute Of Microelectronics And Murata Collaborate To Advance MEMS Technology     9/29/2014
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative With Oregon Health & Science University (OHSU)     9/29/2014
EMD Serono Announces Award Of $1.3 Million To The Winners Of The First Grant For Oncology Innovation     9/29/2014
Keck School Of Medicine Of University of Southern California Receives Federal Administration On Aging Grant To Become The National Center On Elder Abuse     9/29/2014
Arisaph Pharmaceuticals, Inc. Awarded Supplemental Phase I And Phase 2 STTR Grants To Develop Oncology Drug Candidates     9/29/2014
NeurOp Corporation Awarded National Institutes of Health (NIH) Grant For Alzheimer’s Disease Drug Research     9/29/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat     9/29/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season     9/29/2014
Jaguar Animal Health, Inc. Launches First Product, Neonorm™ Calf, At World Dairy Expo     9/29/2014
Opexa Pharmaceuticals, Inc. Strengthens Patent Portfolio With Expansion Into B-Cell Diseases And Announces Allowance Of 98th T-Cell Patent     9/29/2014
Agrisoma Biosciences Inc. Announces Closing Of Series A Round     9/29/2014
ReproCELL Launches Cell Innovation Partners, L.P. With Shinsei Bank, Limited     9/29/2014
Roche (RHHBY) Purchases Shares In Tender Offer For InterMune, Inc. (ITMN)     9/29/2014
Lpath, Inc. (LPTN) Announces Closing of $12.5 Million Registered Direct Offering     9/29/2014
AVANIR Pharmaceuticals (AVNR) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares     9/29/2014
NeoStem, Inc. Secures Debt Facility     9/29/2014
Vitae Pharmaceuticals, Inc. (VTAE) Announces Closing Of Initial Public Offering     9/29/2014
Asterias Biotherapeutics Announces Distribution Date Of Biotime Warrants And Conversion Date Of Series B Common Stock Into Series A Common Stock     9/29/2014
Tesaro, Inc. (TSRO) Announces Closing Of $201.25 Million Public Offering Of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise Of The Underwriters' Option To Purchase Additional Notes     9/29/2014
Alimera Sciences (ALIM) Provides Details On FDA Approval Of ILUVIEN® As The First Long-Term Treatment For Diabetic Macular Edema     9/29/2014
TrovaGene, Inc. Expands Clinical Program With New Study Evaluating Its Precision Cancer Monitoring Platform In Lung Cancer     9/29/2014
Sucampo Pharmaceuticals, Inc. (SCMP) And Takeda Pharmaceutical Co. Ltd. (TKPYY) Launch Direct-To-Consumer Advertising Campaign For AMITIZA ® (Lubiprostone) For Chronic Idiopathic Constipation     9/29/2014
GW Pharmaceuticals Research And Development Day Details     9/29/2014
Seattle Genetics, Inc. (SGEN) To Host Conference Call And Webcast On September 29, 2014 Regarding Top-Line Data From ADCETRIS® (brentuximab vedotin) Phase 3 AETHERA Clinical Trial     9/29/2014
Allergan Inc. (AGN) Board Of Directors Issues Statement     9/29/2014
Opko Health, Inc. Supports National Prostate Cancer Council Legislation     9/29/2014
greenovation Biotech GmbH Release: First GMP-Compliant Batch Of A Biologic Drug Substance From A Moss Expression System Produced For Clinical Use     9/29/2014
Alimera Sciences (ALIM) Provides Details On FDA Approval Of Iluvien® As The First Long-Term Treatment For Diabetic Macular Edema     9/29/2014
Product Innovations And Geographical Expansion Drive Sustained Merck Consumer Health Business Growth     9/29/2014
BioTie Therapies Corp.'s Financial Information In 2015     9/29/2014
Tianyin Pharmaceutical Co, Inc.'s QLF Completes GMP Site Inspection By CFDA     9/29/2014
BioCision, LLC Opens Global Headquarters In San Rafael, California     9/29/2014
Mayor And Mayoress Open Smithers Viscient EU Research Laboratory In Harrogate     9/29/2014
Titian Software Release: TitNew Mosaic 6.0 Makes Sample Management More Intuitive And Cost-Effective     9/29/2014
Phenomenex, Inc. Kinetex® EVO Core-Shell HPLC Columns Deliver Improved Results And Stability From pH 1 To12     9/29/2014
Applied Genetic Technologies Corporation Announces Financial Results For The Quarter And Fiscal Year Ended June 30, 2014     9/29/2014
Bioniche Life Sciences Inc. (BNC) Reports Fiscal 2014 Year-End Results     9/29/2014
Cesca Therapeutics Reports Fourth Quarter And Full Fiscal 2014 Results     9/29/2014
Sevion Therapeutics Reports Fiscal Year 2014 Financial Results     9/29/2014
James Bahel Named Leidos Biomedical Research (SAI) Vice President Of Business Development     9/29/2014
Cerulean Pharma Inc. (CERU) Appoints General Counsel     9/29/2014
Adaptive Biotechnologies Announces The Formation Of A Hematologic Malignancies Scientific Advisory Board     9/29/2014
Atlas Venture Names Jason Rhodes, Veteran Investor And President And CFO Of Epizyme (EPZM), As Partner On Life Sciences Investing Team     9/29/2014
InVivo Therapeutics Corporation (NVIV) Announces Appointment Of Daniel R. Marshak, PhD To Its Board Of Directors     9/29/2014
Dr. Alan E. Smith, Former Chief Scientific Officer Of Genzyme Corporation (GENZ), Joins ImmuneXcite’s Scientific Advisory Board     9/29/2014
Kymab Strengthens And Expands Capabilities Through Board Appointments And Executive Promotions     9/29/2014
Dr. John Stageman Appointed Chair Of The Board For MRC Technology     9/29/2014
Vivione Biosciences Announces Management Changes     9/29/2014
Pfizer Canada And WestJet Make Travel Easier For Canadians With Severe Food Allergies     9/29/2014
Novogen Limited (NVGN) Release: ABC TV Interview Discusses The Potential Of Trilexium(TM) To Treat Brain Cancer     9/29/2014
Eli Lilly and Company (LLY)'s Seventh Global Day Of Service Rallies 24,000 Employees In Nearly 60 Countries     9/29/2014
David H. Murdock To Announce Gift In Perpetuity To DHMRI     9/29/2014
Company Profile For Quintiles, Inc. (Q)     9/29/2014
Romark Laboratories, L.C. Responds To Recent Cryptosporidiosis (Crypto) Outbreak In Florida     9/29/2014
Cellectis Plant Sciences Launches Its New Website     9/29/2014
Presented By The Japanese Cancer Association And Debiopharm Group™, The 'JCA-Mauvernay Award 2014' Goes To Doctors Hara And Shibata     9/29/2014
Clinigen Group plc Receives FDA’s First Ever Drug Shortage Assistance Award     9/29/2014
RabD Biotech Wins Mid-Atlantic Bio Angels Philadelphia 1st Pitch Life Science Competition     9/29/2014
AbbVie (ABBV) Presents Results From Multiple Studies Of Investigational Compound Veliparib In Patients With Non-Small Cell Lung Cancer At The European Society For Medical Oncology Annual Congress     9/29/2014
Cytogel Pharma (Cytogel) Announces Presentation At The 8th Annual Pain And Migraine Therapeutics Summit In Boston On September 24, 2014, Novel Mu Opioid Mechanisms For The Potent Analgesic Cyt-1010 Distinguish It From Morphine     9/29/2014
Compugen Ltd. (CGEN) Announces Presentations Of Results For CGEN-15001 Supporting Immune Tolerance Induction     9/29/2014
RXi Pharmaceuticals (RXII) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum     9/29/2014
MEDTEC Ireland Returns to Galway This October     9/29/2014
OncoMed Pharmaceuticals, Inc. (OMED) Presents Encouraging Data From Clinical Trials Of Tarextumab (Anti-Notch2/3) In Pancreatic Cancer And Small Cell Lung Cancer At The ESMO 2014 Congress     9/29/2014
Applied Genetic Technologies Corporation Leadership To Present At Upcoming Healthcare Conferences     9/29/2014
Cortendo AB To Present At The 14th Annual BIOTECH In Europe Forum In Basel September 30, 2014     9/29/2014
Acceleron Pharma To Webcast Presentation At Leerink Partners Rare Disease Roundtable     9/29/2014
Dicerna Pharmaceuticals (DRNA) To Present At Three Upcoming Investor Conferences     9/29/2014
Catabasis Pharmaceuticals, Inc. To Present At International Congress Of The World Muscle Society     9/29/2014
Novogen Limited (NVGN) Release: Graham Kelly Phd, CEO & Chairman Attended The Rodman & Renshaw 16th Annual Global Investment Conference     9/29/2014
Ocera Therapeutics, Inc. (OCRX) Therapeutics To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum     9/29/2014
Athersys, Inc. (ATHX) To Present At 2014 Stem Cell Meeting On The Mesa     9/29/2014
Clinovo Presents And Sponsors Leading Conferences In September, Including The Annual “Society For Clinical Data Management” (SCDM) Conference     9/29/2014
Helix Biopharma (CC:HBP) To Present At The 2nd Global Life Sciences Conference In Warsaw, Poland     9/29/2014

Career Tips
How To Land The Perfect R&D Job: A Q&A With Luminex Corporation (LMNX)     9/26/2014
The One Job Search Technique That Eliminates Your Competition     9/25/2014
The Secret To Being The Only Person Applying For the Job     9/25/2014
5 Golden Rules For Negotiating Salary     9/25/2014
How To Avoid Resume Clichés     9/25/2014
5 Tips On How To Write An Awesome Cover Letter     9/25/2014
How Biotechs Are Focusing On Employee Retention     9/22/2014
Pfizer (PFE) And Merck & Co. (MRK) Execs Exclusive: Inside Tips For Getting Hired     9/18/2014
6 Job Interview Blunders To Avoid     9/11/2014
What You MUST Ask Before You Leave The Interview     9/11/2014
10 Types Of Positive And Negative Networkers     9/11/2014
How To Craft An Attention-Getting Resume     9/11/2014
Repairing Your Cover Letter And Resume After Getting Fired     9/11/2014
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA)     8/26/2014
Best Biotech Employers In America     8/26/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do

Press Release Submissions
Post your news